These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31839008)

  • 1. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
    Wang R; Li S; Cheng L; Wong MH; Leung KS
    BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTD-DR: Nonnegative tensor decomposition for drug repositioning.
    Jamali AA; Tan Y; Kusalik A; Wu FX
    PLoS One; 2022; 17(7):e0270852. PubMed ID: 35862409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
    Kitsiranuwat S; Suratanee A; Plaimas K
    Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico drug repositioning based on integrated drug targets and canonical correlation analysis.
    Chen H; Zhang Z; Zhang J
    BMC Med Genomics; 2022 Mar; 15(1):48. PubMed ID: 35249529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
    Le DH; Nguyen-Ngoc D
    Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Drug Repositioning Approach Based on Collaborative Metric Learning.
    Luo H; Wang J; Yan C; Li M; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):463-471. PubMed ID: 31283509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid attentional memory network for computational drug repositioning.
    He J; Yang X; Gong Z; Zamit L
    BMC Bioinformatics; 2020 Dec; 21(1):566. PubMed ID: 33297947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Drug-Gene-Disease Associations by Tensor Decomposition for Network-Based Computational Drug Repositioning.
    Kim Y; Cho YR
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network mirroring for drug repositioning.
    Park S; Lee DG; Shin H
    BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing.
    Madugula SS; John L; Nagamani S; Gaur AS; Poroikov VV; Sastry GN
    Comput Biol Med; 2021 Nov; 138():104856. PubMed ID: 34555571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
    Yu L; Zhao J; Gao L
    Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEDD: a network embedding based method for predicting drug-disease associations.
    Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repositioning for Schizophrenia and Depression/Anxiety Disorders: A Machine Learning Approach Leveraging Expression Data.
    Zhao K; So HC
    IEEE J Biomed Health Inform; 2019 May; 23(3):1304-1315. PubMed ID: 30010603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
    Zhao M; Yang CC
    J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.